動脈瘤クリップの世界市場 - 2024年～2031年

動脈瘤クリップの世界市場は2023年に52億4,000万米ドルに達し、2031年には103億1,000万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは8.9%で成長する見込みです。

動脈瘤クリップは、脳動脈瘤の治療に使用される特殊な手術器具です。これらのクリップは通常チタンで構成され、動脈瘤クリッピングとして知られる外科手術中に動脈瘤の頸部に挿入されることを目的としています。これらのクリップの基本的な機能は、動脈瘤を通常の血流から隔離し、効果的に閉塞させ、血液が充満するのを防ぐことです。動脈瘤が破裂すると、出血性脳卒中などの重大な結果を引き起こす可能性があり、死亡や生涯障害のリスクが高まるため、この手術は非常に重要です。

世界の動脈瘤クリップ市場の主な原動力は、外科手術におけるクリップの需要の増加、脳動脈瘤の有病率の増加、クリップにおける改良されたチタン合金の使用によるものです。さらに、クリップは薄いブレード形状でMRIに適合し、組織の完全性を保護します。動脈瘤クリッピング術は動脈瘤の治療に安全で効果的であることが示されているが、全身麻酔と頭蓋骨の切開を必要とする侵襲的な手技です。

市場力学：

促進要因と抑制要因

脳動脈瘤の有病率の増加

脳動脈瘤の有病率の増加は、世界の動脈瘤クリップ市場の成長において重要な要因となることが予想されます。脳動脈瘤の有病率の増加は、世界の動脈瘤クリップ市場の成長に大きな影響を与えると予測されます。脳動脈瘤は、脳の血液動脈の局所的な拡張によって定義され、破裂やその後の出血の可能性を含む深刻な健康被害をもたらします。このような問題に対する人々の意識が高まり、医療技術が進歩するにつれて、動脈瘤クリップのような効果的な治療オプションに対するニーズが高まることが予測されます。高齢者人口の増加や生活習慣に関連した健康状態の悪化が罹患率の増加に寄与していることに加え、手術機器の技術的進歩により、動脈瘤クリップの需要は今後数年間で大幅に増加すると予測されています。

脳動脈瘤の有病率の増加が市場を牽引する主な要因です。例えば、脳動脈瘤財団によると、米国では推定680万人が未破裂の脳動脈瘤を持っており、これは50人に1人の割合です。年間破裂率は10万人当たり約8～10人です。米国では毎年約3万人が脳動脈瘤の破裂に苦しんでいます。18分ごとに脳動脈瘤が破裂しています。脳動脈瘤が原因で死亡する人は世界で毎年50万人近くおり、犠牲者の半数は50歳未満です。そのため、動脈瘤の増加の結果、動脈瘤クリップの需要が増加し、市場を牽引しています。

厳しい規制要件

厳しい規制要件などの要因が、動脈瘤クリップの世界市場を阻害すると予想されます。保健当局が厳しい規制基準を適用するため、世界の動脈瘤クリップ市場は大きな障害に直面しています。米国のFDAや欧州のEMAなどの規制当局は、動脈瘤クリップを含む医療機器の安全性と有効性について厳しい要件を定めています。これらの規制は、新製品を市場に投入する前に、包括的な臨床試験と詳細な文書化を要求します。これらの承認プロセスの複雑さと長さは、技術革新を阻害し、潜在的に有用な製品の発売を遅らせる可能性があります。高いコスト、長い承認手続き、コンプライアンスに伴う不確実性は、技術革新を妨げ、特に経営資源が限られている製造業者の市場機会を制限する可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 脳動脈瘤の罹患率の増加
  • 抑制要因
    • 厳格な規制要件
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 素材の種類別

• チタン
• コバルト
• その他

第7章 動脈瘤の種類別

• 脳
• 胸部
• 腹部
• 周辺

第8章 エンドユーザー別

• 病院と診療所
• 研究センター
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Boston Scientific
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Medtronic
• St. Jude Medical
• Codman & Shurtleff
• KLS Martin Group
• InoMed
• Integra LifeSciences
• Mizuho America
• Stryker Corporation
• B Braun

第12章 付録

The global aneurysm clips market reached US$ 5.24 billion in 2023 and is expected to reach US$ 10.31 billion by 2031, growing at a CAGR of 8.9% during the forecast period 2024-2031.

Aneurysm clips are specialized surgical devices used to treat brain aneurysms, which are bulges caused by damaged blood arteries in the brain. These clips are normally composed of titanium and are intended to be inserted across the neck of an aneurysm during a surgical procedure known as aneurysm clipping. The fundamental function of these clips is to isolate the aneurysm from normal blood flow, effectively closing it off and preventing it from filling with blood. This operation is critical because a ruptured aneurysm can cause serious consequences, such as hemorrhagic stroke, which increases the risk of death or lifelong disability.

The major driving forces global aneurysm clips market are due to increased demand for the clips in surgical operations, increasing prevalence of cerebral aneurysms and the usage of improved titanium alloys in the clips. Additionally, the clips have a thin blade shape and are MRI compatible, protecting tissue integrity. Although aneurysm clipping procedure has shown to be safe and effective in treating aneurysms, it is an invasive procedure that requires general anesthesia and dissection of the skull for the procedure.

Market Dynamics: Drivers & Restraints

Increasing prevalence of cerebral aneurysms

The increasing prevalence of cerebral aneurysms is expected to be a significant factor in the growth of the global aneurysm clips market. The increasing prevalence of cerebral aneurysms is expected to have a significant effect on the growth of the global aneurysm clips market. Cerebral aneurysms, which are defined by localized dilations in the blood arteries of the brain, pose serious health hazards, including the possibility of rupture and subsequent hemorrhage. As people become more aware of these concerns, and medical technology advances, the need for effective treatment options like aneurysm clips is projected to rise. With a growing elderly population and increased lifestyle-related health conditions contributing to greater incidence rates, in addition to technological advancemens in surgical equipment, demand for aneurysm clips is projected to increase significantly in the future years.

The increasing prevalence of cerebral aneurysms is the major factor that is driving the market. For instance, according to the Brain Aneurysm Foundation, an estimated 6.8 million people in the United States have an unruptured brain aneurysm, or 1 in 50 people. The annual rate of rupture is approximately 8 - 10 per 100,000 people. About 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. There are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50. So, as a result of rise in the aneurysms, the demand for the aneurysm clips increases and drives the market.

Stringent regulatory requirements

Factors such as stringent regulatory requirements are expected to hamper the global aneurysm clips market. The global aneurysm clips market confronts considerable obstacles as health authorities apply severe regulatory standards. Regulatory authorities, such as the FDA in the United States and the EMA in Europe, set strict requirements for the safety and efficacy of medical devices, including aneurysm clips. These regulations require comprehensive clinical testing and detailed documentation before new products can be introduced to the market. The complexity and length of these approval processes can stifle innovation and delay the release of potentially helpful products. The high costs, lengthy authorization procedures, and uncertainties associated with compliance can hamper innovation and limit the market opportunity for manufacturers, particularly those with limited resources.

Segment Analysis

The global aneurysm clips market is segmented based on material type, aneurysm type, end-user and region.

Titanium based aneurysm clips segment is expected to dominate the global aneurysm clips market share

Titanium based aneurysm clips segment is expected to dominate the global aneurysm clips market share. The titanium-based aneurysm clips segment is expected to dominate the global aneurysm clip market due to a number of compelling features that highlight the material's distinct advantages. This dominance can be due to titanium's inherent characteristics, which make it ideal for medical uses, notably in neurosurgery. One of the key reasons for using titanium aneurysm clips is their biocompatibility.

Titanium is known for its inertness and non-reactivity, which reduces the possibility of negative reactions when implanted in the human body. This feature is critical in surgical situations because the clips must securely occlude blood arteries without triggering irritation or rejection by the body. In addition, the compatibility with imaging modalities, mainly CT scans, MRI, and X-rays, and its capability to effectively secure the closure of delicate vessels during treatment makes it a preferred option as surgical equipment, thus propelling the growth of the segment.

North America is expected to hold a significant position in the global aneurysm clips market share

North America is expected to maintain its dominant position in the global aneurysm clips market share. This position of prominence is primarily due to a combination of factors, including modern healthcare infrastructure, high aneurysm incidence rates, and significant investments in R&D. The region's well-established medical institutions are supplied with advanced equipment and competent workers, allowing for the widespread use of breakthrough surgical procedures and devices like aneurysm clips. For instance, according to the Brain Aneurysm Foundation, an estimated 6.8 million people in the United States have an unruptured brain aneurysm, or 1 in 50 people. African-Americans and Hispanics are about twice as likely to have a brain aneurysm rupture compared to caucasians.

Research and innovation are critical in sustaining North America's dominant position in the aneurysm clip business. The National Institutes of Health (NIH) has provided major capital for cerebrovascular disease research, which is likely to result in advances in aneurysm clip technology. These advancements not only improve therapeutic efficacy and safety, but also coincide with the emerging trend of minimally invasive surgical methods that are less traumatic to patients.

Asia Pacific is growing at the fastest pace in the global aneurysm clips market

Asia Pacific is experiencing the fastest growth in global aneurysm clips owing to the increasing incidence of brain aneurysms and technological advancements in the region. Technological innovations play an important part in moving the Asia Pacific aneurysm clips market ahead. Aneurysm removal procedures are now more effective and safer due to advances in surgical techniques and materials. The emergence of less invasive procedures has made surgery less stressful for patients while also improving recovery times. These developments are especially advantageous in densely populated areas, where access to surgical care can be limited. The increasing prevalence of brain aneurysms is also one of the major driving factor. For instance, according to an article published in the Times of India, India reports somewhere around 76,500 to 204,100 new cases of brain aneurysms every year.

Competitive Landscape

The major global players in the global aneurysm clips market include Boston Scientific, Medtronic, St. Jude Medical, Codman & Shurtleff, KLS Martin Group, InoMed, Integra LifeSciences, Mizuho America, Stryker Corporation, B Braun, RauMedic among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global aneurysm market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Material Type
• 3.2. Snippet by Aneurysm Type
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Cerebral Aneurysms
  • 4.1.2. Restraints
    • 4.1.2.1. Stringent Regulatory Requirements
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Material Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 6.1.2. Market Attractiveness Index, By Material Type
• 6.2. Titanium*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Cobalt
• 6.4. Others

7. By Aneurysm Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
  • 7.1.2. Market Attractiveness Index, By Aneurysm Type
• 7.2. Cerebral*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Thoracic
• 7.4. Abdominal
• 7.5. Peripheral

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals and Clinics*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Research Centers
• 8.4. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. The U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Boston Scientific*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Medtronic
• 11.3. St. Jude Medical
• 11.4. Codman & Shurtleff
• 11.5. KLS Martin Group
• 11.6. InoMed
• 11.7. Integra LifeSciences
• 11.8. Mizuho America
• 11.9. Stryker Corporation
• 11.10. B Braun

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us